NIH-funded research R21 grant

Targeting hedgehog signaling to model HH and epilepsy in mice

Official title: Targeting hedgehog signaling to model hypothalamic hamartoma and epilepsy in mice

Funded at University of Illinois at Urbana-Champaign · NIH-11454980 · Data updated 2026-11-12

Researchers are developing mouse models of hypothalamic hamartoma to better understand seizures and puberty issues in affected children, using viral and gene-editing tools.

More Epilepsy research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign
NIH-funded
Lab location1 site (Champaign, United States)
Project startSeptember 1, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$225,439
NIH project number1R21NS147341-01A1
Project IDNIH-11454980 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children with hypothalamic hamartoma or related epilepsy features, whose condition could inform translational insights from animal models.

Less likely to help

This basic animal-model project does not directly enroll patients; benefits would come from later translation to human therapies.

What this research studies

This project aims to create and validate new mouse models of hypothalamic hamartoma by disrupting the Sonic hedgehog signaling pathway in targeted hypothalamic cells. The team will use AAV-based viral vectors and CRISPR gene editing to mimic the human condition’s sporadic mutations. By studying these models with electrophysiology and gene expression analyses, they hope to uncover mechanisms of epilepsy and related symptoms and to test potential therapies. The work brings together experts in epilepsy models, puberty control circuits, and molecular genetics to translate findings toward future clinical advances.

Why it matters

Potential benefit: If successful, the project could lead to better understanding of HH-related seizures and puberty issues, guiding the development of targeted therapies.

How similar studies have gone: Previous models of HH are lacking; this project proposes a novel, human-relevant approach using mosaic Shh disruption in mice, which is exploratory.

Where this research is happening

  • University of Illinois at Urbana-Champaign
    Champaign, United States
    Active

Researchers

  • Principal investigator: Christian-Hinman, Catherine a — University of Illinois at Urbana-Champaign
  • Study coordinator: Christian-Hinman, Catherine a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.